Genetics of novel therapeutic targets in schizophrenia
Behavioural pharmacology of the new generation of antipsychotic agents
Neurochemical alterations in schizophrenia affecting the putative receptor targets of atypical antipsychotics : Focus on dopamine (D1, D3, D4) and 5-HT2a receptors
In vivo neuropharmacology of schizophrenia
Critical analysis and comparison of the side-effect and safety profiles of the new antipsychotics*
Cognitive effects of conventional and atypical antipsychotics in schizophrenia
Psychopharmacology of olanzapine : A review